ROCKVILLE, MD — (Marketwire) — 02/12/13 — MarketResearch.com has announced the addition of the report “” to their product offering.
All segments of the drug delivery arena are experiencing rapid evolution. This is particularly evident within the implantable/injectable drug delivery sector. Meeting the challenges of drug delivery that are present today with biopharmaceuticals and emerging drugs requires innovation from drug delivery manufacturers. The expanding occurrence of emerging drugs combined with increased sensitivity to clinical outcomes and healthcare costs are driving the need for alternative drug delivery methods and devices. An aging population, high healthcare costs and healthcare reform initiatives are major forces driving growth.
Drug delivery technology has come into its own in the last 25 years. Initially seen as merely a medium for a drug substance, drug delivery technologies are now viewed as tools for modifying the pharmacologic properties of drugs, improving methods of delivery, and targeting drugs to specific locations. Progress in the fields of microencapsulation, polymer technology and nanoparticles now allow scientists to prolong the effect of drugs with short half-lives. Companies are developing a new generation of sophisticated delivery systems. Targeted delivery has already advanced with new polymer-based chemotherapy implants. The geographic scope of the report is worldwide.
Large pharmaceutical companies have realized that they can substantially extend the period of exclusivity (and the competitive edge) of their products that are about to lose patent protection by delivering them in a novel way. This leads to a competitive edge after patent expiration or patent extension. Patent issues are a major driver of the industry. This leads to the development of collaborations and acquisitions between Big Pharma companies and drug delivery companies. Pharmaceutical manufacturers are seeking alternatives to conventional delivery systems to introduce patients to innovative platforms that promote compliance and reduce risks. This is putting pressure on the drug delivery companies to meet the demands and remain competitive in the implantable/injectable drug delivery. Within the implantable/injectable drug delivery market, there are a number of competitors. Competition in the segment has increased over the past 10 years, with top delivery technology companies such as ALZA, Pacira, Bioject, and Alkermes.
For more information, visit
Follow us on Facebook
Follow us on Twitter
, a division of MarketResearch.com, is a leader in worldwide business intelligence and syndicated market research in the life sciences. With a more than 30-year history of providing timely, high-quality research to decision makers in the pharmaceutical, biotechnology, medical device, and diagnostics sectors, Kalorama comprehensively researches the market sectors and healthcare trends that matter most to emerging and established life science firms.
MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world-s most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com-s Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance. For more information, call Cindy Frei at 240.747.3014 or visit .
Cindy Frei
MarketResearch.com
240.747.3014
You must be logged in to post a comment Login